Compare Google Inc (GOOG) vs Mesoblast Limited (MESO) Price & Performance

Google IncTrade

Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Google Inc vs Mesoblast Limited — how do they compare? Google Inc trades at $370.68 (market cap $4.52T), while Mesoblast Limited trades at $18.77 (market cap $2.31B). The key difference: Google Inc is far larger — about 1956.7× Mesoblast Limited's market cap, and Google Inc pays a 0.24% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.

	GOOG	MESO
Market Cap	$4.52T	$2.31B
Volume	1,511,127	—
Sector	Technology	Technology
52-Week High	$399.06	$20.96
52-Week Low	$183.77	$11.35
Enterprise Value	$4.49T	$2.32B
Dividend Yield	0.24%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

Alphabet (GOOG) trades at $370.43, up 3.67% on the day, with strong bullish momentum from recent earnings beats and a consensus analyst price target of $457.50. The stock shows robust fundamentals with 2025 revenue of $402.84B, net income margin of 37.92%, and consistent cash flow growth. Technical indicators are bullish, with the current price near resistance at $374, while sentiment is positive due to Warren Buffett's recent endorsement and AI-driven growth prospects.

Outlook remains favorable with earnings growth and AI expansion as key catalysts, though regulatory risks and market volatility pose challenges. The stock offers upside potential aligned with analyst targets, supported by high institutional ownership and strong profitability metrics.

Mesoblast Limited

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GOOG

Alphabet stock rises on AI, cloud growth, and strong investor backing including Berkshire Hathaway.Tony Dante · 7 hours agoBullish Alphabet stock rises after legal win and Berkshire Hathaway's big investmentTony Dante · 8 hours agoBullish US ITC investigates Samsung and partners for alleged patent infringement on memory products.PRNewsWire · 9 hours agoBearish View details →

MESO

Mesoblast completes treatment of 300 patients in Phase 3 trial for chronic low back pain therapy.GlobeNewsWire · 2 days agoBullish View details →

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.